Overview A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer Status: Recruiting Trial end date: 2023-03-01 Target enrollment: Participant gender: Summary This is an open-label, non-controlled study conducted in two parts - Part A (dose escalation) followed by Part B (dose expansion). Phase: Phase 1 Details Lead Sponsor: Nitto BioPharma, Inc.